Calcium response after stimulation by Substance P of U373 MG cells:Inhibition of store-operated calcium entry by protein kinase C

Cell Calcium

Volumn 35, Issue 2, 2004, Pages 123-130

  Galiano, Maria ^a   Gasparre, Giuseppe ^a   Lippe, Claudio ^a   Cassano, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Protein kinase C; Substance P; U373 MG cell

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL; CALCIUM ION; CALPHOSTIN C; PROTEIN KINASE C; SUBSTANCE P; TACHYKININ; THAPSIGARGIN;

ARTICLE; ASTROCYTOMA CELL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPERPOLARIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; SENSITIVITY ANALYSIS;

EID: 0942266255     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2003.07.001     Document Type: Article

References (39)

1. M.J. Berridge, P. Lipp, M.D. Bootman, The versatility and universatility of calcium signalling, Nat. Rev. Mol. Cell Biol. 1 (2000) 11-21.
2. I. Bosanac, J.R. Alattia, T.K. Mal, J. Chan, S. Talarico, F.K. Tong, K.I. Tong, F. Yoshikawa, T. Furuichi, M. Iwai, T. Michikawa, K. Mikoshiba, M. Ikura, Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand, Nature 420 (2002) 696-700.
3. 2+-release channels, Cell Calcium 32 (2002) 307-319.
4. K. Venkatachalam, D.B. van Rossum, R.L. Patterson, H.T. Ma, D.L. Gill, The cellular and molecular basis of store-operated calcium entry, Nat. Cell Biol. 4 (2002) E263-E272.
5. J.W. Putney Jr., R.R. McKay, Capacitative calcium entry channels, Bioessays 21 (1999) 38-46.
6. A.B. Parekh, R. Penner, Store depletion and calcium influx, Physiol. Rev. 77 (1997) 901-930.
7. M.J. Berridge, Calcium signalling and cell proliferation, Bioessays 17 (1995) 491-500.
8. E.C. Kohn, E. Reed, G. Sarosy, M. Christian, C.J. Link, K. Cole, W.D. Figg, P.A. Davis, J. Jacob, B. Goldspiel, L.A. Liotta, Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers, Cancer Res. 56 (1996) 569-573.
9. K.S. Bauer, W.D. Figg, J.M. Hamilton, E.C. Jones, A. Premkumar, S.M. Steinberg, V. Dyer, W.M. Linehan, J.M. Pluda, E. Reed, A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer, Clin. Cancer Res. 5 (1999) 2324-2329.
10. S. Peuchen, J.B. Clark, M.R. Duchen, Mechanisms of intracellular calcium regulation in adult astrocytes, Neuroscience 71 (1996) 871-883.
11. T. Brismar, Physiology of transformed glial cells, Glia 15 (1995) 231-243.
12. C. Severini, G. Improta, G. Falconieri-Erspamer, S. Salvadori, V. Erspamer, The tachykinin peptide family, Pharmacol. Rev. 54 (2002) 285-322.
13. 1 receptors in progression of human gliomas, Life Sci. 67 (2000) 985-1001.
14. M.W. Roe, J.J. Lemasters, B. Herman, Assessment of Fura-2 for measurements of cytosolic free calcium, Cell Calcium 11 (1990) 63-73.
15. 2+] with fluorescent indicators, Methods Cell Biel. 40 (1994) 155-181.
16. D. Regoli, G. Drapeau, S. Dion, R. Couture, New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization, Trends Pharmacol. Sci. 9 (1988) 290-295.
17. C. Tousignant, G. Guillemette, G. Drapeau, D. Regoli, Comparison of binding assay and biological activity on a NK-1 system with new selective agonists, Neuropeptides 14 (1989) 275-283.
18. S.K. Bohm, E.F. Grady, N.W. Bunnett, Regulatory mechanisms that modulate signalling by G-protein-coupled receptors, Biochem. J. 322 (1997) 1-18.
19. 2+ stores, J. Biol. Chem. 267 (1992) 108-118.
20. 2+ response elicited by bradykinin in human skin fibroblasts, Gen. Pharmacol. 32 (1999) 239-244.
21. C.R. Jan, C.M. Ho, S.N. Wu, C.J. Tseng, Mechanism of rise and decay of thapsigargin-evoked calcium signals in MDCK cells, Life Sci. 64 (1999) 259-267.
22. 2+ store in A7r5 and 16HBE14o-cells, J. Biol. Chem. 277 (2002) 6898-6902.
23. 2 receptors, Mol. Pharmacol. 49 (1996) 438-446.
24. M.A. Leissring, Y. Akbari, C.M. Fanger, M.D. Cahalan, M.P. Mattson, F.M. La Ferla, Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice, J. Cell Biol. 149 (2000) 793-798.
25. 2+ influx by B cell receptor cross-linking, J. Immunol. 166 (2) (2001) 1003-1008.
26. A.B. Parekh, R. Penner, Depletion-activated calcium current is inhibited by protein kinase in RBL-2H3 cells, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7907-7911.
27. K. Venkatachalam, F. Zheng, D.L. Gill, Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C, J. Biol. Chem. 278 (2003) 29031-29040.
28. M. Sharif, Mitogenic signalling by Substance P and bombesin-like neuropeptide receptors in astrocytic/glial brain tumor-derived cell lines, Int. J. Oncol. 12 (1998) 272-286.
29. W. Luo, T.R. Sharif, P.J. Houghton, M. Sharif, CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein (MAP) kinase activation and c-Fos phosphoprotein induction by Substance P in human astrocytoma cells, Cell Growth Differ. 8 (1997) 1225-1240.
30. G. Vazquez, B.J. Wedel, M. Trebak, G.St. John Bird, J.W. Putney, Expression level of the canonical transient receptor potential 3 (TRPC3) channel determines its mechanism of activation, J. Biol. Chem. 278 (2003) 21649-21654.
31. 2+ concentration in the store lumen, EMBO J. 17 (1998) 435-442.
32. 2+-ATPase in rat microvascular endothelial cells, Biochem. J. 364 (2002) 235-244.
33. J.H. Gaddum, Tryptamine receptors, J. Physiol. 119 (1953) 363-368.
34. 2+ in rat parotid acinar cells, Biochem. Biophys. Res. Commun. 148 (1987) 1017-1024.
35. 1) receptors at sites of inflammation, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8964-8968.
36. 2+] dynamics measured in agonist-sensitive stores of single living intact cells: a new look at the refilling process, EMBO J. 17 (1998) 1986-1995.
37. K.P. Lu, A.R. Means, Regulation of the cell cycle by calcium and calmodulin, Endocr. Rev. 14 (1993) 40-58.
38. 2+ entry in human arterial myocytes, Am. J. Physiol. 277 (1999) C343-C349.
39. 2+ mobilization and activation of NF-kappaB and NEAT, Nat. Immunol. 2 (2001) 403-409.